Evidence map›Paper›PMID 26854668›Full record

ArticleNature chemical biology2016

Engineering nonphosphorylative metabolism to generate lignocellulose-derived products.

Yi-Shu Tai, Mingyong Xiong, Pooja Jambunathan, Jingyu Wang, Jilong Wang, Cole Stapleton, Kechun Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Nature chemical biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Metabolic bottlenecks ofMetabolic engineering communications · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yi-Shu TaiDepartment of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, Minnesota, USA.
Mingyong XiongDepartment of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, Minnesota, USA.
Pooja JambunathanDepartment of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, Minnesota, USA.
Jingyu WangDepartment of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, Minnesota, USA.
Jilong WangDepartment of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, Minnesota, USA.
Cole StapletonDepartment of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, Minnesota, USA.
Kechun ZhangDepartment of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, Minnesota, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Conversion of lignocellulosic biomass into value-added products provides important environmental and economic benefits. Here we report the engineering of an unconventional metabolism for the production of tricarboxylic acid (TCA)-cycle derivatives from D-xylose, L-arabinose and D-galacturonate. We designed a growth-based selection platform to identify several gene clusters functional in Escherichia coli that can perform this nonphosphorylative assimilation of sugars into the TCA cycle in less than six steps. To demonstrate the application of this new metabolic platform, we built artificial biosynthetic pathways to 1,4-butanediol (BDO) with a theoretical molar yield of 100%. By screening and engineering downstream pathway enzymes, 2-ketoacid decarboxylases and alcohol dehydrogenases, we constructed E. coli strains capable of producing BDO from D-xylose, L-arabinose and D-galacturonate. The titers, rates and yields were higher than those previously reported using conventional pathways. This work demonstrates the potential of nonphosphorylative metabolism for biomanufacturing with improved biosynthetic efficiencies.

Indexed as

ArabinoseBiosynthetic PathwaysButylene GlycolsEscherichia coliHexuronic AcidsKetoglutaric AcidsLigninMetabolic EngineeringMultigene FamilyXylose1,4-butanediolArabinoseButylene Glycolsgalacturonic acidHexuronic AcidsKetoglutaric AcidsLigninlignocelluloseXylose

Identifiers

PMID26854668

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.